Recently, rare cases of LS-like MLH1-deficient (MLH1-d) cancers associated with high-risk constitutional MLH1 methylation (epimutation) have been described, with a prevalence of <1% of MLH1-d methylated tumors [22]. The gene discussed is MLH1; the disease is cancer.